<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03622632</url>
  </required_header>
  <id_info>
    <org_study_id>263425</org_study_id>
    <nct_id>NCT03622632</nct_id>
  </id_info>
  <brief_title>Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association</brief_title>
  <official_title>Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital du Sacre-Coeur de Montreal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hopital du Sacre-Coeur de Montreal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this project, is to better understand the fluctuation of the level of uric acid
      in traumatized patients by making serial measurements during their hospitalization in the
      intensive care unit. In addition, the determinants (e.g. type of trauma, diseases,
      interventions) of the blood level of uric acid and its association with the development of
      organ failure will be sought.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 30, 2018</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of serial plasmatic uric acid sampling after trauma</measure>
    <time_frame>7 days</time_frame>
    <description>Number of measures collected/number of measures planned</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of resuscitation on uric acid measures</measure>
    <time_frame>24 to 48 hours</time_frame>
    <description>Impact of fluid administration (amount in mL) on the changes of subsequent uric acid blood level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical predictors of the first blood uric acid (μmol/L) level measured</measure>
    <time_frame>12 hours</time_frame>
    <description>Impact of patient's characteristics and physiological variables on the first measured blood uric acid.
Characteristics will include: age (years), gender, Injury severity score, presence of acute renal impairment.
Physiological variables will include: lower systolic blood pressure, base deficit, lactate level</description>
  </secondary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Trauma</condition>
  <condition>Inflammation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Multiple trauma patients admitted in the trauma center and requiring ICU admission.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Direct admission to trauma center

          -  ≤ 3h after trauma

          -  ISS ≥ 16

          -  Received at least 1L of fluid at ER entrance

        Exclusion Criteria:

          -  Isolated head injury

          -  Isolated spine injury

          -  Chemotherapy within the last month

          -  Hematologic disease

          -  Chronic hemodialysis

          -  Uricase treatment within the last week

          -  Expected death within 48h
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital du Sacré-Cœur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>August 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>February 16, 2020</last_update_submitted>
  <last_update_submitted_qc>February 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital du Sacre-Coeur de Montreal</investigator_affiliation>
    <investigator_full_name>Emmanuel Charbonney</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>uric acid</keyword>
  <keyword>organ failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

